Fractionated conformal radiotherapy for management of optic nerve sheath meningiomas: long-term outcomes of tumor control and visual function at a single institution.
OBJECTIVE
To provide the long-term outcomes of patients treated with fractionated conformal radiotherapy (FCRT) for presumed optic nerve sheath meningiomas (ONSMs).


METHODS
Between 1995 and 2002, 9 patients with a presumed ONSM were treated with FCRT at our institution. The indications for FCRT were significant visual dysfunction at presentation, progression of visual dysfunction during a period of observation, tumor growth documented by sequential imaging, or a combination of these findings. In 2 patients, FCRT was performed as adjuvant therapy, and in 7, it was the initial and primary treatment.


RESULTS
Of the 9 patients, 6 were women and 3 were men, with a mean age of 47 years. All 9 patients had evidence of optic nerve dysfunction in the affected eye, characterized by reduced visual acuity, a visual field defect, and a relative afferent pupillary defect. In addition, 2 patients had proptosis and 1 had diplopia. The mean follow-up period was 98 ± 31.7 months (median, 90; range, 61-151). After FCRT, the visual function improved in the 7 patients who had undergone FCRT as the primary treatment. However, 2 patients who were blind in their affected eye at FCRT remained blind. In 4 of the 7 patients with improvement, the improvement was documented within 1-3 months after FCRT. The tumor control rate was 100%. Proptosis and diplopia also regressed in 100% of patients. At 2 years after FCRT, 1 patient had developed radiation retinopathy.


CONCLUSIONS
The results of our study have shown that FCRT is a safe and effective treatment of ONSMs, affording satisfactory long-term tumor control, good functional outcome, and low treatment morbidity. FCRT should be considered the treatment of choice for patients with presumed ONSMs for whom the treatment has been deemed appropriate.
Metellus
Philippe
P
Department of Neurosurgery, Johns Hopkins Hospital, Baltimore, MD 21287, USA.
Kapoor
Sumit
S
Kharkar
Siddharth
S
Batra
Sachin
S
Jackson
Juan F
JF
Kleinberg
Lawrence
L
Miller
Neil R
NR
Rigamonti
Daniele
D
D000328:Adult; D018450:Disease Progression; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008577:Meningeal Neoplasms / Q000150:complications / Q000473:pathology / Q000532:radiotherapy*; D008579:Meningioma / Q000150:complications / Q000473:pathology / Q000532:radiotherapy*; D008875:Middle Aged; D009186:Myelin Sheath; D019574:Optic Nerve Neoplasms / Q000150:complications / Q000473:pathology / Q000532:radiotherapy*; D011880:Radiotherapy Planning, Computer-Assisted; D020266:Radiotherapy, Conformal / Q000009:adverse effects / Q000379:methods*; D016896:Treatment Outcome; D047368:Tumor Burden; D014786:Vision Disorders / Q000209:etiology*; D014792:Visual Acuity
J Med Assoc Thai. 2006 Oct;89(10):1665-9
17128842
J Clin Neuroophthalmol. 1990 Sep;10(3):185-7
2144535
Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1422-9
12459365
Ophthalmology. 2002 May;109(5):890-9; discussion 899-900
11986093
Neurosurgery. 2003 Jul;53(1):62-70; discussion 70-1
12823874
Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):755-63
7960976
Ophthalmology. 2005 Aug;112(8):1484
16080233
Arch Ophthalmol. 2006 Mar;124(3):379-85
16534058
Br J Ophthalmol. 1980 Aug;64(8):553-8
7426572
Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):537-43
12738331
J Neuroophthalmol. 2005 Jun;25(2):86-91
15937428
J Neuroophthalmol. 1996 Dec;16(4):247-51
8956159
Neurosurgery. 2002 May;50(5):950-5; discussion 955-7
11950397
Ann Acad Med Singap. 2006 Mar;35(3):168-74
16625265
Ophthalmology. 2004 Mar;111(3):565-7
15019337
BMJ. 1992 May 23;304(6838):1343-6
1611331
J Neurosurg. 1999 Jan;90(1):42-9
10413154
Surv Ophthalmol. 1992 Nov-Dec;37(3):167-83
1475751
J Neuroophthalmol. 2007 Jun;27(2):143-4
17549002
Ophthalmology. 2003 Oct;110(10):2019-30
14522782
Ophthalmology. 1992 Apr;99(4):560-6
1584575
Radiother Oncol. 2004 Aug;72(2):169-74
15297135
Oncology (Williston Park). 1996 Jun;10(6):837-47; discussion 847-8, 851-2
8823799
Acta Neurochir (Wien). 1994;126(1):27-32
8154318
Neurosurg Focus. 2003 May 15;14(5):e7
15669818
J Neuroophthalmol. 2006 Sep;26(3):200-8
16966942
Neurosurgery. 2002 Oct;51(4):890-902; discussion 903-4
12234395
Eye (Lond). 2004 Nov;18(11):1026-37
15534587
J Neurosurg. 1998 Jan;88(1):43-50
9420071
Clin Radiol. 1982 Mar;33(2):181-7
7067351
Am J Ophthalmol. 1988 Oct 15;106(4):450-7
3177564
Neurochirurgie. 2007 Nov;53(5):333-8
17707866
Clin Exp Ophthalmol. 2005 Apr;33(2):137-41
15807820
Neurosurgery. 2002 Dec;51(6):1373-79; discussion 1379-80
12445342